Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | GMNN | O75496 | 1/20 | 0.48 |
| ▸ | PPM1B | O75688 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.48 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | PPP5C | P53041 | 1/20 | 0.48 |
| ▸ | PPP1CA | P62136 | 1/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | THPO | P40225 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | APEX1 | P27695 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10028639 | 1.00 | TDP1 (0.48) | TDP1KDM4EGMNNPPM1BLMNA | |
| SCHEMBL10029224 | 1.00 | TDP1 (0.48) | TDP1KDM4EGMNNPPM1BLMNA | |
| SCHEMBL351863 | 1.00 | TDP1 (0.48) | TDP1KDM4EGMNNPPM1BLMNA | |
| SCHEMBL21117867 | 1.00 | TDP1 (0.48) | TDP1KDM4EGMNNPPM1BLMNA | |
| SCHEMBL5833458 | 1.00 | TDP1 (0.48) | TDP1KDM4EGMNNPPM1BLMNA | |
| SCHEMBL16199087 | 0.90 | TDP1 (0.44) | TDP1KDM4EGMNNPPM1BLMNA | |
| SCHEMBL3199039 | 0.90 | TDP1 (0.44) | TDP1KDM4EGMNNPPM1BLMNA | |
| SCHEMBL6519226 | 0.90 | SMN1; SMN2 (0.44) | TDP1KDM4EGMNNPPM1BLMNA | |
| SCHEMBL6127457 | 0.90 | TDP1 (0.44) | TDP1KDM4EGMNNPPM1BLMNA | |
| SCHEMBL18723992 | 0.90 | TDP1 (0.44) | TDP1KDM4EGMNNPPM1BLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 199 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240327561-A1 | FLUOROPOLYMER AND CYCLIC OLEFIN ALLOY | DAIKIN AMERICA, INC. (US) | 2024-10-03 | — | — | US | claimed |
| CN-117567397-A | Method for preparing internal bicyclo (2.2.2) oct-5-ene-2, 3-dicarboxylic anhydride | 杭州迪克科技有限公司 | 2024-02-20 | — | — | CN | claimed |
| WO-2023112948-A1 | FLUOROPOLYMER AND CYCLIC OLEFIN ALLOY | DAIKIN AMERICA, INC. (US) | 2023-06-22 | — | — | WO | claimed |
| US-20220119584-A1 | Degradable Urethane and Urethane-Urea Systems | LANXESS CORPORATION (US) | 2022-04-21 | — | — | US | claimed |
| US-20010047043-A1 | Method of preparing a polymerizate | PPG INDUSTRIES OHIO, INC. | 2001-11-29 | — | — | US | claimed |
| US-20260092157-A1 | MACROPOROUS-STRUCTURED POLYMER AEROGELS | BLUESHIFT MAT INC (US) | 2026-04-02 | — | — | US | disclosed |
| EP-4127157-B1 | MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS | ENCODIA INC (US) | 2026-02-11 | — | — | EP | disclosed |
| US-12516172-B2 | Macroporous-structured polymer aerogels | Blueshift Materials, Inc. (US) | 2026-01-06 | — | — | US | disclosed |
| EP-4655158-A2 | FLAME AND THERMAL BARRIER MATERIALS | Blueshift Materials, Inc. (US) | 2025-12-03 | — | — | EP | disclosed |
| US-20250353984-A1 | HIGHLY BRANCHED NON-CROSSLINKED AEROGEL, METHODS OF MAKING, AND USES THEREOF | BLUESHIFT MAT INC (US) | 2025-11-20 | — | — | US | disclosed |
| US-20250346018-A1 | LOW-DIELECTRIC CONSTANT, LOW-DISSIPATION FACTOR LAMINATES INCLUDING AEROGEL LAYERS | BLUESHIFT MAT INC (US) | 2025-11-13 | — | — | US | disclosed |
| US-12404382-B2 | Highly branched non-crosslinked aerogel, methods of making, and uses thereof | Blueshift Materials, Inc. (US) | 2025-09-02 | — | — | US | disclosed |
| US-5994469-A | Curable coating composition containing a resin with latent functionality | BASF CORPORATION (US) | 1999-11-30 | — | — | US | disclosed |
| EP-0905208-A1 | Curable coating composition having latent functionality | BASF CORPORATION (US) | 1999-03-31 | — | — | EP | disclosed |
| EP-0662496-A2 | Additives for paintable and printable polyolefin compositions | Th. Goldschmidt AG (DE) | 1995-07-12 | — | — | EP | disclosed |
| EP-0655053-A1 | BICYCLOOCTANE AND BICYCLOHEPTANE DERIVATIVES. | BLACK JAMES FOUNDATION (GB) | 1995-05-31 | — | — | EP | disclosed |
| EP-0637306-A1 | 4-IMIDOMETHYL-1- 2'PHENYL-2'OXOETHYL-] PIPERIDINES AS SEROTONIN 5HT 2?-ANTAGONISTS, THEIR PREPARATION AND USE IN THERAPY | MERRELL PHARMACEUTICALS INC. (US) | 1995-02-08 | — | — | EP | disclosed |
| WO-1993022309-A1 | 4-IMIDOMETHYL-1-[2'PHENYL-2'OXOETHYL-] PIPERIDINES AS SEROTONIN 5HT2-ANTAGONISTS, THEIR PREPARATION AND USE IN THERAPY | MERRELL DOW PHARMACEUTICALS INC. (US) | 1993-11-11 | — | — | WO | disclosed |
| WO-1993000395-A1 | ADDITIVES WHICH STABILIZE HYDROHALOCARBON BLOWING AGENT IN POLYURETHANE AND POLYISOCYANURATE FOAM FORMULATIONS DURING POLYMERIZATION | ALLIED-SIGNAL INC. (US) | 1993-01-07 | — | — | WO | disclosed |
| US-5137929-A | Additives which stabilize hydrohalocarbon blowing agent in polyurethane and polyisocyanurate foam formulations during polymerization | ALLIED-SIGNAL INC. (US) | 1992-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092157-A1 | MACROPOROUS-STRUCTURED POLYMER AEROGELS | ACR, AQP4, AQP3 | TDP1 1146/4885KDM4E 2403/4885GMNN 4340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.